TSPYL2 and renal fibrosis: In this study, we demonstrate that the deletion of CDA1 at week 5 after induced diabetes, mimicking the therapeutic inhibition of CDA1 once renal injury is developing, led to an attenuation in diabetes-associated renal fibrosis.